Regeneron Pharmaceuticals, Inc.
Non-human animals having a humanized B-cell activating factor gene
Last updated:
Abstract:
Non-human animals, cells, methods and compositions for making and using the same are provided, wherein the non-human animals and cells comprise a humanized B-cell activating factor gene. Non-human animals and cells that express a human or humanized B-cell activating factor protein from an endogenous B-cell activating factor locus are described.
Status:
Grant
Type:
Utility
Filling date:
8 Jan 2019
Issue date:
11 May 2021